drugset / Trial / NCT00293800

A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

NCT00293800

Phase 3 Completed 173 enrolled Alcon Research
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to evaluate the safety and effectiveness of an investigational glaucoma therapy in patients with open-angle glaucoma or ocular hypertension.

Timeline

Start
2004-07
Primary completion
2005-12
Completion
2005-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Latanoprost Small molecule 0.005 % Other
Comparator Timolol Other / unclassified 0.5 % Other
Subject Travoprost Other / unclassified 0.004 % Other